78 related articles for article (PubMed ID: 19408892)
1. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
Richter E; Engl J; Friesenegger S; Tricker AR
Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Upadhyaya P; Kalscheuer S; Hochalter JB; Villalta PW; Hecht SS
Chem Res Toxicol; 2008 Jul; 21(7):1468-76. PubMed ID: 18570389
[TBL] [Abstract][Full Text] [Related]
3. Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Ma B; Zarth AT; Carlson ES; Villalta PW; Upadhyaya P; Stepanov I; Hecht SS
Chem Res Toxicol; 2018 Jan; 31(1):48-57. PubMed ID: 29131934
[TBL] [Abstract][Full Text] [Related]
4. Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Zhang S; Wang M; Villalta PW; Lindgren BR; Upadhyaya P; Lao Y; Hecht SS
Chem Res Toxicol; 2009 May; 22(5):926-36. PubMed ID: 19358518
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA adducts in the lung and liver of F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and (S)-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Stepanov I; Hecht SS
Chem Res Toxicol; 2009 Feb; 22(2):406-14. PubMed ID: 19166332
[TBL] [Abstract][Full Text] [Related]
6. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
Hecht SS; Stepanov I; Carmella SG
Acc Chem Res; 2016 Jan; 49(1):106-14. PubMed ID: 26678241
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.
Balbo S; Johnson CS; Kovi RC; James-Yi SA; O'Sullivan MG; Wang M; Le CT; Khariwala SS; Upadhyaya P; Hecht SS
Carcinogenesis; 2014 Dec; 35(12):2798-806. PubMed ID: 25269804
[TBL] [Abstract][Full Text] [Related]
8. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
[TBL] [Abstract][Full Text] [Related]
9. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone modulation of cytokine release in U937 human macrophages.
Rioux N; Castonguay A
Cancer Immunol Immunother; 2001 Feb; 49(12):663-70. PubMed ID: 11258792
[TBL] [Abstract][Full Text] [Related]
10. Dihydromethysticin (DHM) Blocks Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-Induced O
Narayanapillai SC; Lin SH; Leitzman P; Upadhyaya P; Baglole CJ; Xing C
Chem Res Toxicol; 2016 Nov; 29(11):1828-1834. PubMed ID: 27728767
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-electrospray ionization-tandem mass spectrometry quantitation of urinary [pyridine-D4]4-hydroxy-4-(3-pyridyl)butanoic acid, a biomarker of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation in smokers.
Jing M; Wang Y; Upadhyaya P; Jain V; Yuan JM; Hatsukami DK; Hecht SS; Stepanov I
Chem Res Toxicol; 2014 Sep; 27(9):1547-55. PubMed ID: 25098652
[TBL] [Abstract][Full Text] [Related]
12. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.
Wei B; Blount BC; Xia B; Wang L
J Expo Sci Environ Epidemiol; 2016; 26(3):249-56. PubMed ID: 25564369
[TBL] [Abstract][Full Text] [Related]
13. An update on the formation in tobacco, toxicity and carcinogenicity of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Peterson LA; Stanfill SB; Hecht SS
Carcinogenesis; 2024 May; 45(5):275-287. PubMed ID: 38437625
[TBL] [Abstract][Full Text] [Related]
14. Influence of UGT2B10 Genotype on Urinary Excretion of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol- N-glucuronide by African American Smokers.
Murphy SE; von Weymarn LB; Parenteau M; Stepanov I; Tiirikainen M; LeMarchand L; Park SL
Chem Res Toxicol; 2018 Mar; 31(3):168-175. PubMed ID: 29460622
[TBL] [Abstract][Full Text] [Related]
15. Coexposure to Inhaled Aldehydes or Carbon Dioxide Enhances the Carcinogenic Properties of the Tobacco-Specific Nitrosamine 4-Methylnitrosamino-1-(3-pyridyl)-1-butanone in the A/J Mouse Lung.
Peterson LA; Oram MK; Flavin M; Seabloom D; Smith WE; O'Sullivan MG; Vevang KR; Upadhyaya P; Stornetta A; Floeder AC; Ho YY; Zhang L; Hecht SS; Balbo S; Wiedmann TS
Chem Res Toxicol; 2021 Mar; 34(3):723-732. PubMed ID: 33629582
[TBL] [Abstract][Full Text] [Related]
16. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.
Church TR; Anderson KE; Caporaso NE; Geisser MS; Le CT; Zhang Y; Benoit AR; Carmella SG; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):260-6. PubMed ID: 19124507
[TBL] [Abstract][Full Text] [Related]
17. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
Yuan JM; Knezevich AD; Wang R; Gao YT; Hecht SS; Stepanov I
Carcinogenesis; 2011 Sep; 32(9):1366-71. PubMed ID: 21734256
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive High-Resolution Mass Spectrometric Analysis of DNA Phosphate Adducts Formed by the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Ma B; Villalta PW; Zarth AT; Kotandeniya D; Upadhyaya P; Stepanov I; Hecht SS
Chem Res Toxicol; 2015 Nov; 28(11):2151-9. PubMed ID: 26398225
[TBL] [Abstract][Full Text] [Related]
19. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
Yuan JM; Koh WP; Murphy SE; Fan Y; Wang R; Carmella SG; Han S; Wickham K; Gao YT; Yu MC; Hecht SS
Cancer Res; 2009 Apr; 69(7):2990-5. PubMed ID: 19318550
[TBL] [Abstract][Full Text] [Related]
20. Alveolar macrophage cytotoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke.
Proulx LI; Paré G; Bissonnette EY
Cancer Immunol Immunother; 2007 Jun; 56(6):831-8. PubMed ID: 17096151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
